Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

McKesson Corp Add to portfolio

INX:MCK, Jul 18, 08:56 UTC

Latest INX:MCK News

Filter your feed

Apply Filter

Thursday, July 12


News

McKesson Applauds DOJ Policy Change on Opioid Quotas

MCK

SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation today praised the U.S. Department of Justice’s decision to exercise its authority to reduce opioid production if the agency believes a particular drug is highly diverted. The annual opioid production quota determines the total amount of controlled substances that can be produced each year. This new rule calls on the Drug Enforcement Administration to carefully assess which drugs are being diverted – an important part of the effort to curb opioid misuse and abuse.”. McKesson is deeply concerned by the impact the opioid epidemic is having on families and communities across the nation—and is committed to being part of the solution.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Wednesday, July 11


News

McKesson ideaShare Exhibitors Donate to Nevada Childhood Cancer Foundation - Press Release

MCK

More than 170 exhibitors of the premier independent pharmacy conference, McKesson ideaShare 2018, will donate 1000s of personal hygiene items, including soap, shampoo and toothpaste to Nevada Childhood Cancer Foundation (NCCF) on behalf of families of children diagnosed with cancer. WHEN:. Established in 1993, Nevada Childhood Cancer Foundation (NCCF) is a local non-profit organization providing over 45 programs and services at no cost to pediatric and adult patients and their families living in Southern Nevada. The NCCF’s goal is to improve the quality of life for critically ill children, their families, and adults touched by cancer in the community. When a child is diagnosed with cancer or other life-threatening illness… they look to NCCF for support, hope, and courage. Celebrating more than 35 years as the premier community pharmacy education and networking event, McKesson ideaShare 2018 is an interactive forum for independent pharmacists to improve their knowledge, performance and profitability.

Read Full Details

Topics:
  • Business
  • Health
  • Entertainment
  • Science

Monday, July 09


News

Will Core Distribution Unit Aid McKesson (MCK) Q1 Earnings?

MCK

McKesson Corporation’s MCK first-quarter fiscal 2019 earnings are scheduled to release on Jul 26, before the market opens. While the quarterly results are likely to drive growth at the core Distribution Solutions segment, its strategic initiatives might boost the bottom line. However, McKesson’s performance in the fourth quarter of fiscal 2018 lacked luster, with adjusted earnings of $3.49 per share missing the Zacks Consensus Estimate. Notably, McKesson has delivered a positive average earnings surprise of 5.2% in the trailing four quarters. Coming to the geographical analysis of Distribution Solutions, the Zacks Consensus Estimate for North America Pharmaceutical Distribution and Services revenues stands at $44.09 billion, up 2.5% from the year-ago quarter. Per our proven model, a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) to deliver a positive earnings surprise in the fiscal first quarter.

Read Full Details

Topics:
  • Business
  • Financial
News

Rockland Trust Co Increases Stake in Mckesson Corp (MCK)

MCK

178.18 million shares or 0.22% more from 177.79 million shares in 2017Q4 were reported. Parkwood Limited Liability Co has 0.06% invested in McKesson Corporation (NYSE:MCK) for 3,007 shares. Prudential Public Ltd Company holds 0.53% of its portfolio in McKesson Corporation (NYSE:MCK) for 1.20M shares. More notable recent McKesson Corporation (NYSE:MCK) news were published by: Seekingalpha.com which released: “McKesson: Market Overreaction” on June 29, 2018, also Seekingalpha.com with their article: “UPS – A Stock For Your Watchlist” published on June 11, 2018, Gurufocus.com published: “My Favorite Stock in the S&P 500 Today” on July 06, 2018.

Read Full Details

Topics:
  • Business
  • Financial
  • Entertainment
News

Power of Community Pharmacies Showcased at McKesson ideaShare

MCK

“It makes me a better pharmacist, and it makes my pharmacy a better practice for our customers.” Song is leading one of the 100 educational sessions for the more than 2,000 pharmacies represented at McKesson ideaShare. “McKesson continues to invest in clinical solutions, revenue generating tools and technology designed to help independent pharmacies provide quality care for their patients, while also improving their business performance,” said Nick Loporcaro, president, McKesson U.S. Pharmaceutical and Specialty Health. The power of Health Mart Atlas will ensure that community pharmacies are included in the right networks to continue to provide quality care to patients and perform to their highest potential as the industry evolves to value-based care models. In the exhibit hall, Health Mart Atlas experts will be on hand to discuss performance opportunities and action plans recommended by the myHealthMart and myMcKesson tools, including profitability reports and the DIR (direct and indirect remuneration) Estimator tool.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Thursday, July 05


News

McKesson Corporation Fiscal 2019 First Quarter Conference Call Scheduled for July 26, 2018

MCK

McKesson Corporation (MCK) will release financial results for its first fiscal quarter ended June 30, 2018 on Thursday, July 26, 2018, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results. McKesson Corporation, currently ranked 6th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

McKesson's INVIVA Infusion Clinics become Canada's first accredited private infusion network

MCK

MISSISSAUGA, ON, July 5, 2018 /CNW Telbec/ - McKesson Canada's INVIVA network has met Accreditation Canada's Qmemtum Accreditation Program requirements and become the first accredited private infusion clinic network in Canada. "We are committed to providing patients with the best possible access to quality care, closer to home, more conveniently, and in a way that meets their care needs from coast-to-coast " said Norine Primeau-Menzies, Vice President and General Manager INVIVA. McKesson Canada's INVIVA clinics successfully completed the Qmentum Accreditation Program and received full accreditation at all locations across Canada now through April 2022. Our solutions empower pharmacies, manufacturers, hospitals and other health care institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada. For more information, please visit www.mckesson.ca.

Read Full Details

Topics:
  • Business
  • Health
  • Politics
  • Financial

Tuesday, July 03


News

McKesson Corporation (MCK) Analysts See $2.71 EPS

MCK

It is positive, as 73 investors sold McKesson Corporation shares while 263 reduced holdings. 178.18 million shares or 0.22% more from 177.79 million shares in 2017Q4 were reported. Charter Trust Com owns 0.13% invested in McKesson Corporation (NYSE:MCK) for 7,273 shares. Since March 1, 2018, it had 0 buys, and 2 sales for $334,327 activity. Analysts expect McKesson Corporation (NYSE:MCK) to report $2.71 EPS on July, 26.They anticipate $0.25 EPS change or 10.16 % from last quarter’s $2.46 EPS.

Read Full Details

Topics:
  • Business
  • Financial
  • Health
News

Key Analysts at Morgan Stanley Maintain their 'Equal-Weight' rating for Diplomat Pharmacy (NYSE:DPLO) Shares Today. Their Target Price per Share Given is $21

MS MCK +1 more MS MCK ABC

Key Analysts at Morgan Stanley Reconfirmed their ‘”Equal-Weight”’ rating for McKesson (NYSE:MCK) Shares Today. It is positive, as 73 investors sold McKesson Corporation shares while 263 reduced holdings. 141,847 were accumulated by Panagora Asset Management Inc. Stanley Cap Management reported 3.54% in McKesson Corporation (NYSE:MCK). Since March 1, 2018, it had 0 insider purchases, and 2 insider sales for $334,327 activity. The stock of McKesson Corporation (NYSE:MCK) earned “Buy” rating by Cowen & Co on Wednesday, April 18. As per Thursday, February 1, the company rating was maintained by Mizuho.

Read Full Details

Topics:
  • Business
  • Financial
  • Health

Friday, June 29


News

McKesson (MCK) Issues Strong Preliminary Results for Q1

MCK

McKesson Corporation MCK declared preliminary results for the first quarter of fiscal 2019. The Zacks Consensus Estimate for earnings is pegged at $2.67, which is below the guidance. McKesson Corporation Price and Consensus | McKesson Corporation Quote. However, following the announcement, the company’s shares inched down1.8% in the last trading session and closed at $135.80. Not to forget, during fourth-quarter earnings call, management announced that the U.S. Pharmaceutical and Specialty Solutions is expected to deliver low- to mid-single digit revenue growth.

Read Full Details

Topics:
  • Business
  • Financial